Literature DB >> 17303283

Second-order interactions with the treatment groups in controlled clinical trials.

Shyang-Yun Pamela K Shiao1, Chul W Ahn, Kouhei Akazawa.   

Abstract

The occurrence of significant second-order interactions for group characteristics was examined using real data in a randomized controlled trial (RCT). The interactions exist in all RCTs; they could be easily overlooked when using the simple randomization or stratification methods, but could become more obvious when minimization methods are used. Using real data from an RCT, the minimization method enabled balancing the distributions of the four selected stratified factors. Analyses for three-way second-order interactions including six additional potential confounding variables (for a total of 10 variables) presented 8 significant second-order interactions with the treatment groups. Interaction effects need to be evaluated when treatment effects are examined to maximize the power of the treatment effects in any RCTs. A stepwise regression method with piecewise linear functions would be useful to select the significant variables with interaction effects affecting the treatment outcomes in RCTs. Additional ways to handle interaction effects in RCTs are presented in this paper.

Mesh:

Year:  2007        PMID: 17303283      PMCID: PMC1858675          DOI: 10.1016/j.cmpb.2006.12.004

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  19 in total

Review 1.  Evidence-based medicine: its effect on treatment recommendations as illustrated by the changing role of postmastectomy irradiation to treat breast cancer.

Authors:  Seymour H Levitt; Dorothee Aeppli; Mary Beth Nierengarten
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

2.  Power of logrank test and Cox regression model in clinical trials with heterogeneous samples.

Authors:  K Akazawa; T Nakamura; Y Palesch
Journal:  Stat Med       Date:  1997-03-15       Impact factor: 2.373

3.  Minimization: a new method of assigning patients to treatment and control groups.

Authors:  D R Taves
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

4.  The randomization and stratification of patients to clinical trials.

Authors:  M Zelen
Journal:  J Chronic Dis       Date:  1974-09

5.  The impact of covariate imbalance on the size of the logrank test in randomized clinical trials.

Authors:  N Kinukawa; T Nakamura; K Akazawa; Y Nose
Journal:  Stat Med       Date:  2000-08-15       Impact factor: 2.373

6.  How many stratification factors are "too many" to use in a randomization plan?

Authors:  T M Therneau
Journal:  Control Clin Trials       Date:  1993-04

Review 7.  Research within the field of blood and marrow transplantation nursing: how can it contribute to higher quality of care?

Authors:  Monica C Fliedner
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

8.  Allocation of patients to treatment in clinical trials.

Authors:  S J Pocock
Journal:  Biometrics       Date:  1979-03       Impact factor: 2.571

9.  Randomized clinical trials in pediatric critical care: Rarely done but desperately needed.

Authors:  Adrienne G. Randolph; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2002-04       Impact factor: 3.624

Review 10.  The method of minimization for allocation to clinical trials. a review.

Authors:  Neil W Scott; Gladys C McPherson; Craig R Ramsay; Marion K Campbell
Journal:  Control Clin Trials       Date:  2002-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.